ENGAIN Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ENGAIN Co., Ltd. - overview
Established
2011
Location
Hwaseong, Gyeonggi, South Korea
Primary Industry
Medical Devices & Equipment
About
Founded in 2011 and based in South Korea, ENGAIN Co. , Ltd. operates as a researcher, developer, and manufacturer of medical devices specializing in therapeutic products based on Biomacromolecule Synthesis Technology. In May 2022, ENGAIN Co.
, Ltd. raised KRW 5. 5 billion in venture funding from investors AJU IB Investment, KNet Investment Partners, and other unspecified investors, valuing the company at KRW 56. 38 billion post-money.
ENGAIN's products include a stimuli-responsive Colorimetric Sensing platform, embolic-therapeutic materials, medical adhesive in wound healing, and non-thermal, non-tumescent varicose vein treatment devices in the permanent closure of lower extremity superficial truncal veins, such as the great saphenous vein (GSV). Engain conducts research and development in two areas - treatment materials and diagnostic technology.
Current Investors
LSK Investment, Genaxis, DS Asset Management
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.engain.co.kr
Verticals
Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
ENGAIN Co., Ltd. - timeline of key events
ENGAIN Co., Ltd. - financials
| Fiscal Year Ended | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 182,350,000 | 259,176,000 | 412,778,483 | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | 42.1% | 59.3% | - | - | - | - | - | - | - |
| EBITDA (USD) | (1,063,978,015) | (1,536,576,708) | (2,200,910,812) | - | - | - | - | - | - | - |
| Operating Income (USD) | (1,150,271,155) | (1,669,338,678) | (2,403,963,947) | - | - | - | - | - | - | - |
| Operating Margin | (630.8%) | (644.1%) | (582.4%) | - | - | - | - | - | - | - |
| % EBITDA Margin | (583.5%) | (592.9%) | (533.2%) | - | - | - | - | - | - | - |
| NET Income (USD) | (1,691,013,502) | (2,155,980,083) | (3,215,546,631) | - | - | - | - | - | - | - |
| % Net Margin | (927.3%) | (831.9%) | (779.0%) | - | - | - | - | - | - | - |
ENGAIN Co., Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.